BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30604076)

  • 21. Management of gallbladder disease after sleeve gastrectomy in a selected Lebanese population.
    Dakour Aridi H; Sultanem S; Abtar H; Safadi BY; Fawal H; Alami RS
    Surg Obes Relat Dis; 2016 Aug; 12(7):1300-1304. PubMed ID: 27178610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery.
    Amstutz S; Michel JM; Kopp S; Egger B
    Obes Surg; 2015 Nov; 25(11):2054-60. PubMed ID: 25804356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy.
    Li VK; Pulido N; Fajnwaks P; Szomstein S; Rosenthal R; Martinez-Duartez P
    Surg Endosc; 2009 Jul; 23(7):1640-4. PubMed ID: 19057954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
    Mulliri A; Menahem B; Alves A; Dupont B
    J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
    Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
    Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid.
    Coupaye M; Calabrese D; Sami O; Msika S; Ledoux S
    Surg Obes Relat Dis; 2017 Apr; 13(4):681-685. PubMed ID: 28089591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
    Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
    Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study.
    Manatsathit W; Leelasinjaroen P; Al-Hamid H; Szpunar S; Hawasli A
    Int J Surg; 2016 Jun; 30():13-8. PubMed ID: 27063855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic gallstones after sleeve gastrectomy.
    Li VK; Pulido N; Martinez-Suartez P; Fajnwaks P; Jin HY; Szomstein S; Rosenthal RJ
    Surg Endosc; 2009 Nov; 23(11):2488-92. PubMed ID: 19347402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of symptomatic gallstones after bariatric surgery: the impact of expectant management.
    Nogueiro J; Santos-Sousa H; Ribeiro M; Cruz F; Pereira A; Resende F; Costa-Pinho A; Preto J; Sousa-Pinto B; Lima-da-Costa E; Carneiro S
    Langenbecks Arch Surg; 2023 Apr; 408(1):160. PubMed ID: 37093281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
    Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
    Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
    Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
    Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity.
    Hashimoto K; Nagao Y; Nambara S; Tsuda Y; Kudou K; Kusumoto E; Sakaguchi Y; Kusumoto T; Ikejiri K
    Obes Surg; 2022 Oct; 32(10):3404-3409. PubMed ID: 36006591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.
    Coogan AC; Williams MD; Krishnan V; Skertich NJ; Becerra AZ; Sarran M; Schimpke S; Torquati A; Omotosho P
    Obes Surg; 2023 Aug; 33(8):2361-2367. PubMed ID: 37392353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
    Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
    Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
    Haal S; Guman MSS; Bruin S; Schouten R; van Veen RN; Fockens P; Dijkgraaf MGW; Hutten BA; Gerdes VEA; Voermans RP
    Obes Surg; 2022 Apr; 32(4):1270-1278. PubMed ID: 35143012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
    Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
    Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass.
    Mishra T; Lakshmi KK; Peddi KK
    Obes Surg; 2016 Oct; 26(10):2411-7. PubMed ID: 26910024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
    Alimoğulları M; Buluş H
    Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.